SurGenTec Signs Exclusive License Deal for Vantage System

SurGenTec has entered into an exclusive license agreement with Allevion Medical for the Vantage spinal decompression system, according to 01net, which published the Business Wire announcement.

The reported agreement centers on Vantage, a spinal decompression system. SurGenTec is described in the announcement as a privately held medical device company focused on advancing treatment options for orthopedic and spine surgery.

Agreement brings Vantage into focus

01net reported that SurGenTec announced the exclusive license agreement with Allevion Medical. The announcement identifies the Vantage system as a spinal decompression technology and places the transaction within SurGenTec’s orthopedic and spine surgery focus.

Neither the supplied announcement summary nor the report details additional commercial terms, product specifications, implementation milestones, or territory information.

Relevance for medical device sales teams

For professionals working across spine and orthopedic device markets, the announcement highlights a licensing transaction involving a spinal decompression system. The named companies are SurGenTec and Allevion Medical, and the product named in the agreement is the Vantage spinal decompression system.

Sales professionals tracking the spine segment may want to note how companies frame technology relationships, product portfolios, and treatment-focused positioning in their customer conversations. The available report specifically characterizes SurGenTec’s work as focused on treatment options for orthopedic and spine surgery.

What was announced

• SurGenTec announced an exclusive license agreement with Allevion Medical.
• The agreement involves the Vantage spinal decompression system.
• The announcement describes SurGenTec as a privately held medical device company focused on orthopedic and spine surgery treatment options.

The announcement was reported by 01net and attributed to Business Wire.